查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944263

全球戒烟和尼古丁成瘾治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Smoking Cessation and Nicotine De-Addiction Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计戒烟和尼古丁成瘾治疗市场规模将从 2025 年的 364.6 亿美元成长到 2034 年的 907.3 亿美元，2026 年至 2034 年的复合年增长率为 10.66%。

随着公共卫生措施的推进和人们对吸烟危害认识的不断提高，戒烟和尼古丁成瘾治疗市场正经历着模式转移，对有效戒烟方案的需求日益增长。随着越来越多的人寻求戒烟，尼古丁替代疗法（NRT）、处方药和行为支持计画的市场正在扩大。吸烟相关健康问题的日益增加进一步推动了这一增长，促使各国政府和医疗机构加大对综合戒烟计画的投入，为寻求戒烟的人们提供支持和资源。

此外，数位健康技术的兴起正在改变戒烟支持的格局。行动应用程式和线上平台正成为为戒烟者提供个人化支援、进度监控和激励的宝贵工具。这些数位解决方案通常融合了行为科学原理，为使用者提供个人化的策略来应对烟瘾和诱因。随着技术的进步，人工智慧和机器学习的融入将进一步提升这些平台的效能，并为使用者提供更精准的介入和支援。

此外，电子烟和加热烟草製品等替代尼古丁输送系统的日益普及正在重塑戒烟市场。儘管这些产品通常被宣传为危害较小的替代品，但它们仍然构成公共卫生挑战。随着监管机构评估这些替代方案的长期影响，戒烟市场必须做出调整，提供能够满足不同戒烟者多样化需求的全面解决方案。因此，在创新、技术进步以及旨在改善公共卫生状况的合作努力的推动下，戒烟和尼古丁成瘾治疗市场有望迎来显着成长。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球戒烟和尼古丁成瘾治疗市场（按类型划分）

  • 市场分析、洞察与预测
  • 尼古丁替代疗法
  • 药物治疗
  • 电子烟

5. 全球戒烟和尼古丁成瘾治疗市场（按形式划分）

  • 市场分析、洞察与预测
  • 胶
  • 吸入器
  • 药片
  • 其他的

6. 全球戒烟和尼古丁成瘾治疗市场（依分销管道划分）

  • 市场分析、洞察与预测
  • 医院药房
  • 在线的
  • 药局和零售药房

7. 全球戒烟和尼古丁成瘾治疗市场（按地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Rusan Pharma Ltd
    • Dr. Reddy'S Laboratories Ltd
    • Imperial Brands Plc
    • Zydus Group
    • British American Tobacco Plc
    • Perrigo Company Plc
    • Johnson And Johnson Inc
    • Njoy LLC
    • Cipla Ltd
    • GlaxoSmithKline Plc
简介目录
Product Code: VMR11218851

The Smoking Cessation and Nicotine De-Addiction Market size is expected to reach USD 90.73 Billion in 2034 from USD 36.46 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The smoking cessation and nicotine de-addiction market is witnessing a paradigm shift as public health initiatives and growing awareness of the dangers of smoking drive demand for effective cessation solutions. With an increasing number of individuals seeking to quit smoking, the market for nicotine replacement therapies (NRTs), prescription medications, and behavioral support programs is expanding. This growth is further fueled by the rising prevalence of smoking-related health issues, prompting governments and healthcare organizations to invest in comprehensive smoking cessation programs that provide support and resources for individuals looking to quit.

Moreover, the advent of digital health technologies is transforming the smoking cessation landscape. Mobile applications and online platforms are emerging as valuable tools that offer personalized support, tracking, and motivation for individuals on their journey to quit smoking. These digital solutions often incorporate behavioral science principles, providing users with tailored strategies to manage cravings and triggers. As technology continues to evolve, the integration of artificial intelligence and machine learning into these platforms will enhance their effectiveness, enabling more precise interventions and support for users.

Additionally, the increasing popularity of alternative nicotine delivery systems, such as e-cigarettes and heated tobacco products, is reshaping the smoking cessation market. While these products are often marketed as less harmful alternatives, they still pose challenges for public health. As regulatory bodies assess the long-term effects of these alternatives, the smoking cessation market will need to adapt, offering comprehensive solutions that address the diverse needs of individuals seeking to quit. The smoking cessation and nicotine de-addiction market is thus positioned for significant growth, driven by innovation, technology, and a collective commitment to improving public health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Nicotine Replacement Therapy
  • Drug Therapy
  • E-cigarettes

By Form

  • Gum
  • Inhaler
  • Tablet
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Online
  • Drug Stores and Retail Pharmacies

COMPANIES PROFILED

  • Rusan Pharma Ltd, Dr Reddys Laboratories Ltd, Imperial Brands Plc, Zydus Group, British American Tobacco Plc, Perrigo Company Plc, Johnson and Johnson Inc, Njoy LLC, Cipla Ltd, GlaxoSmithKline Plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Nicotine Replacement Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. E-cigarettes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY FORM 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Form
  • 5.2. Gum Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Inhaler Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Tablet Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Distribution Channel
  • 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Drug Stores and Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Form
    • 7.2.3 By Distribution Channel
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Form
    • 7.3.3 By Distribution Channel
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Form
    • 7.4.3 By Distribution Channel
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Form
    • 7.5.3 By Distribution Channel
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Form
    • 7.6.3 By Distribution Channel
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Rusan Pharma Ltd
    • 9.2.2 Dr. Reddy'S Laboratories Ltd
    • 9.2.3 Imperial Brands Plc
    • 9.2.4 Zydus Group
    • 9.2.5 British American Tobacco Plc
    • 9.2.6 Perrigo Company Plc
    • 9.2.7 Johnson And Johnson Inc
    • 9.2.8 Njoy LLC
    • 9.2.9 Cipla Ltd
    • 9.2.10 GlaxoSmithKline Plc